CAML β€” PROFESIONALLY MANAGED PORTFO

Ownership history in MORGAN STANLEY  Β·  6 quarters on record

This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in PROFESIONALLY MANAGED PORTFO (CAML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

MORGAN STANLEY Γ— CAML AI Analytics

πŸ“‰ MORGAN STANLEY underperformed the S&P 500 by –3.1% annually on this CAML position. Average cost basis: $33.02. Maximum drawdown during holding period: –6.3%.

πŸ“ˆ Position Alpha vs SPY
-3.1%
annualised excess return

⚠️ Trailed SPY by 3.1% ann. on this position.
5 quarters analyzed

πŸ’° Entry Quality
$33.02
+15.6% vs current ($38.17)

Best entry: $33.02 (2024 Q3)  Β·  Worst: $33.02 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–6.3%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
50%
buy-side decisions

1 add Β· 1 trim. Bought during 0 of 2 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    CAML price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 1,272 β€” 0% 0.00% $49K $38.17
2025 Q3 UNCHANGED 1,272 β€” 0% 0.00% $49K $38.79
2025 Q2 REDUCED 1,272 -545 -30.0% 0.00% $47K $36.67
2025 Q1 UNCHANGED 1,817 β€” 0% 0.00% $58K $31.81
2024 Q4 UNCHANGED 1,817 β€” 0% 0.00% $62K $33.95
2024 Q3 INITIATED 1,817 β€” β€” 0.00% $60K $33.02
← Back to MORGAN STANLEY Holdings